Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases Indian Medical PG Practice Questions and MCQs

Question 211: Which of the following statements about Octreotide is incorrect?

A. It is a somatostatin analogue.
B. It is used in secretory diarrhea in AIDS.
C. It is used in carcinoid syndrome.
D. It acts as an absorbent. (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. It acts as an absorbent.** **1. Why Option D is the correct (incorrect statement):** Octreotide is a **pharmacological agent**, specifically a synthetic octapeptide analogue of the hormone somatostatin. It does not act physically as an absorbent (like Kaolin or Pectin, which bind toxins and water in the gut lumen). Instead, it works by binding to specific somatostatin receptors (SSTR-2, 3, and 5) to inhibit the secretion of various hormones and intestinal fluids. **2. Analysis of Incorrect Options (Correct Statements):** * **Option A:** Octreotide is indeed a **somatostatin analogue**. It is preferred over natural somatostatin because it has a much longer half-life (approx. 1.5 hours vs. 2 minutes) and can be administered subcutaneously or intravenously. * **Option B:** It is a standard treatment for **refractory secretory diarrhea** associated with AIDS and chemotherapy. It works by inhibiting intestinal secretion and enhancing water/electrolyte absorption. * **Option C:** It is the drug of choice for symptomatic relief in **Carcinoid Syndrome** and VIPomas. It suppresses the release of serotonin and other vasoactive peptides that cause flushing and diarrhea. **3. Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits the release of Growth Hormone (GH), Glucagon, Insulin, Gastrin, and VIP. * **Other Uses:** * **Acromegaly:** To reduce GH levels. * **Esophageal Varices:** It causes splanchnic vasoconstriction, reducing portal pressure (though Terlipressin is often preferred). * **Dumping Syndrome:** Post-gastrectomy. * **Key Side Effect:** **Gallstones (Cholelithiasis)** due to inhibition of cholecystokinin (CCK) release and reduced gallbladder contractility. * **Steatorrhea:** May occur due to inhibition of pancreatic enzyme secretion.

Question 212: All of the following are true for metoclopramide except?

A. Chemically related to procainamide
B. Speeds gastric emptying
C. Stimulates the chemoreceptor trigger zone (Correct Answer)
D. Blocks D2 receptors

Explanation: **Explanation:**Metoclopramide is a substituted benzamide, a prokinetic agent, and a potent antiemetic [1]. The correct answer is **Option C** because metoclopramide **blocks** (antagonizes) the Chemoreceptor Trigger Zone (CTZ), rather than stimulating it. **Why Option C is the correct answer (The Exception):**Metoclopramide acts as an antiemetic primarily by blocking **D2 receptors** in the CTZ of the medulla. By inhibiting these receptors, it raises the threshold for vomiting. Stimulating the CTZ would induce nausea and vomiting, which is the opposite of metoclopramide’s clinical use. **Analysis of Incorrect Options:** * **Option A (Chemically related to procainamide):** This is true. Metoclopramide is a derivative of para-aminobenzoic acid (PABA), making it chemically related to the antiarrhythmic drug procainamide, though it lacks significant antiarrhythmic activity. * **Option B (Speeds gastric emptying):** This is true. As a **prokinetic**, it increases lower esophageal sphincter tone and enhances gastric motility/emptying by blocking inhibitory D2 receptors and enhancing Acetylcholine release (5-HT4 agonism) in the enteric nervous system [2]. * **Option D (Blocks D2 receptors):** This is true. Its primary mechanism of action both centrally (antiemetic) and peripherally (prokinetic) involves D2 receptor antagonism. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects:** Due to central D2 blockade, it can cause **Extrapyramidal Symptoms (EPS)** like acute dystonia and Parkinsonism. It also increases prolactin levels, leading to galactorrhea or gynecomastia. * **Drug of Choice:** It is frequently used for Diabetic Gastroparesis and as an antiemetic in post-operative states or chemotherapy [1]. * **Contraindication:** It must be avoided in patients with **Pheochromocytoma** (can cause hypertensive crisis) and mechanical GI obstruction.

Question 213: Which of the following drugs is NOT used in the management of IBS-Constipation?

A. Lubiprostone
B. Tegaserod
C. Alosetron (Correct Answer)
D. Linaclotide

Explanation: **Explanation:** The correct answer is **Alosetron** because it is used in the management of **IBS-Diarrhea (IBS-D)**, not IBS-Constipation (IBS-C). **Mechanism and Rationale:** * **Alosetron** is a potent **5-HT₃ receptor antagonist**. By blocking these receptors in the enteric nervous system, it reduces intestinal motility, decreases secretions, and increases visceral pain thresholds. Because it slows colonic transit, it is indicated specifically for severe, diarrhea-predominant IBS in women who have not responded to conventional therapy. **Analysis of Incorrect Options (Drugs used for IBS-C):** * **Lubiprostone (Option A):** A **Chloride Channel Activator (Type-2)**. It increases fluid secretion into the intestinal lumen, which softens stool and accelerates transit time. * **Tegaserod (Option B):** A **5-HT₄ receptor partial agonist**. Stimulation of 5-HT₄ receptors triggers the peristaltic reflex and promotes gastric emptying and intestinal transit. (Note: Its use is restricted due to cardiovascular risks). * **Linaclotide (Option D):** A **Guanylate Cyclase-C (GC-C) agonist**. It increases intracellular cGMP, which activates the CFTR channel to secrete chloride and bicarbonate into the lumen, facilitating bowel movements and reducing visceral pain. **High-Yield NEET-PG Pearls:** 1. **Alosetron Warning:** It is associated with a rare but serious risk of **Ischemic Colitis**, requiring a strict prescribing program. 2. **Prucalopride:** Another 5-HT₄ agonist (highly selective) used for chronic constipation. 3. **Eluxadoline:** A mu-opioid receptor agonist used for IBS-D. 4. **Rifaximin:** A non-absorbable antibiotic often used for IBS-D to modulate gut flora.

Question 214: Which drugs are used in the treatment of pruritus in Primary Biliary Cholangitis (PBC)?

A. Rifampicin
B. Naltrexone
C. Cholestyramine
D. All of the above (Correct Answer)

Explanation: **Explanation:** Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease where the accumulation of bile acids and other pruritogens (like endogenous opioids and lysophosphatidic acid) leads to severe, debilitating pruritus. The management follows a stepwise pharmacological approach: 1. **Cholestyramine (Option C):** This is the **first-line treatment**. It is a bile acid sequestrant (resin) that binds bile salts in the intestinal lumen, preventing their enterohepatic circulation and promoting fecal excretion. * *Clinical Pearl:* It must be taken 1 hour after or 4 hours before other drugs to avoid interference with absorption. 2. **Rifampicin (Option A):** This is the **second-line treatment**. It acts as a potent inducer of the Pregnane X Receptor (PXR). This increases the metabolism of bile acids and pruritogens (via CYP3A4) and enhances their excretion. 3. **Naltrexone (Option B):** This is an **opioid antagonist**. Cholestasis leads to an increased "opioidergic tone," which contributes to the sensation of itching. Naltrexone blocks these opioid receptors to provide relief. **Why "All of the Above" is correct:** All three drugs target different pathways of the cholestatic itch—sequestration (Cholestyramine), enzymatic metabolism (Rifampicin), and receptor antagonism (Naltrexone). Therefore, all are established therapeutic options for PBC-associated pruritus. **High-Yield Facts for NEET-PG:** * **Sertraline** (an SSRI) is often used as a fourth-line agent. * **Ursodeoxycholic acid (UDCA)** is the first-line drug for the *progression* of PBC but is generally ineffective for treating the *symptom* of pruritus. * **Plasmapheresis** or **Liver Transplant** are considered for refractory cases.

Question 215: Proton pump inhibitors (PPIs) are used in which of the following conditions?

A. Zollinger-Ellison syndrome
B. NSAID-induced peptic ulcer
C. Gastroesophageal reflux disease
D. All of the above (Correct Answer)

Explanation: **Explanation:** Proton Pump Inhibitors (PPIs) like Omeprazole and Pantoprazole are the most potent inhibitors of gastric acid secretion [1], [2]. They work by irreversibly inhibiting the **H+/K+ ATPase pump** (the final common pathway for acid secretion) in the gastric parietal cells [1], [2]. **Why "All of the above" is correct:** * **Zollinger-Ellison Syndrome (ZES):** This is a gastrin-secreting tumor (gastrinoma) leading to extreme gastric acid hypersecretion. PPIs are the **drugs of choice** here [1], often requiring higher doses than standard peptic ulcer disease to control the massive acid output. * **NSAID-induced Peptic Ulcer:** NSAIDs inhibit prostaglandin synthesis, weakening the mucosal barrier. PPIs are highly effective in both the **healing and prevention** of NSAID-induced gastric and duodenal ulcers [1]. * **Gastroesophageal Reflux Disease (GERD):** PPIs are the mainstay of treatment for symptomatic relief and healing of erosive esophagitis [1], [2]. They are superior to H2 blockers in maintaining a gastric pH >4, which is essential for esophageal healing [1]. **High-Yield Clinical Pearls for NEET-PG:** 1. **Mechanism:** PPIs are **prodrugs** that require an acidic environment for activation (converted to sulfenamide) [1]. 2. **Administration:** They should be taken **30–60 minutes before meals** (usually breakfast) because the number of H+/K+ ATPase pumps is highest after a period of fasting. 3. **Drug Interactions:** Omeprazole can inhibit CYP2C19, potentially reducing the activation of **Clopidogrel**. 4. **Long-term Side Effects:** Chronic use is associated with Vitamin B12 deficiency, hypomagnesemia, and an increased risk of *C. difficile* infections and osteoporotic fractures (due to decreased calcium absorption).

Question 216: Which of the following is NOT an osmotic laxative?

A. Sorbitol
B. Magnesium Hydroxide
C. Polyethylene glycol
D. Bisacodyl (Correct Answer)

Explanation: ### Explanation The correct answer is **D. Bisacodyl**. **1. Why Bisacodyl is the correct answer:** Bisacodyl is classified as a **stimulant (irritant) laxative**, not an osmotic one. It works by directly irritating the sensory nerve endings in the colonic mucosa and stimulating the myenteric plexus. This increases propulsive peristaltic activity and alters electrolyte transport, leading to fluid accumulation in the gut lumen. It is commonly used for acute constipation or bowel preparation before procedures. **2. Why the other options are incorrect:** Osmotic laxatives are non-absorbable substances that retain water in the intestinal lumen through osmotic pressure, softening the stool and increasing bolus volume. * **Sorbitol:** A non-absorbable sugar alcohol that acts as an osmotic agent. * **Magnesium Hydroxide (Milk of Magnesia):** A saline osmotic laxative. Magnesium ions are poorly absorbed and draw water into the intestines. * **Polyethylene glycol (PEG):** A high-molecular-weight polymer that is metabolically inert and non-absorbable. It is considered the gold standard for chronic constipation and whole-gut irrigation. **3. NEET-PG High-Yield Clinical Pearls:** * **Mechanism of Stimulant Laxatives:** They can cause "cathartic colon" (loss of normal colonic motility) with chronic overuse. * **Lactulose:** Another high-yield osmotic laxative; it is also used in **Hepatic Encephalopathy** to trap ammonia ($NH_3$) as ammonium ions ($NH_4^+$) in the gut. * **Bulk-forming agents:** Psyllium (Ispaghula) and Methylcellulose are the first-line treatments for most chronic constipation cases. * **Docusate:** Acts as a stool softener (surfactant/emulsifier) rather than a stimulant or osmotic agent.

Question 217: All of the following are true regarding a patient with acid peptic disease except?

A. Misoprostol is the drug of choice in patients on NSAIDs.
B. Duodenal ulcer is preventable by the use of single nighttime H2 blockers.
C. Omeprazole may help ulcers refractory to H2 blockers. (Correct Answer)
D. Misoprostol is the drug of choice in pregnant patients.

Explanation: This question is designed to test your knowledge of the management of Acid Peptic Disease (APD) and the contraindications of specific drugs. ### **Explanation of the Correct Answer** The question asks for the **"EXCEPT"** (false) statement. While **Option C** is technically a true clinical statement (PPIs like Omeprazole are indeed superior and used for H2-blocker refractory ulcers), the provided key indicates a discrepancy in the question's logic or a potential typo in the source material. However, in the context of standard medical exams, **Option D is the most definitively false statement.** Misoprostol is a prostaglandin E1 analog that increases uterine contractions and is a known **abortifacient**. Therefore, it is strictly **contraindicated in pregnancy** (Category X). ### **Analysis of Options** * **Option A:** Misoprostol is specifically effective in preventing NSAID-induced gastric ulcers because it replaces the protective prostaglandins inhibited by NSAIDs. * **Option B:** H2 blockers (like Ranitidine) are effective at suppressing nocturnal acid secretion, which is the primary driver of duodenal ulcer formation. A single nighttime dose is a standard prophylactic regimen. * **Option C:** PPIs (Omeprazole) provide more potent and prolonged acid suppression than H2 blockers, making them the gold standard for refractory cases. * **Option D:** This is **false**. Misoprostol is used for medical abortion (often with Mifepristone) and is never the drug of choice for APD in a pregnant patient. Sucralfate or H2 blockers are preferred. ### **NEET-PG High-Yield Pearls** * **Drug of Choice (DOC) for NSAID-induced ulcers:** PPIs are now preferred over Misoprostol due to better tolerability, but Misoprostol remains the "pharmacological" DOC in textbooks. * **Misoprostol Side Effects:** Diarrhea (most common) and abdominal cramps. * **PPI Mechanism:** Irreversible inhibition of $H^+/K^+$ ATPase (Proton Pump). * **Zollinger-Ellison Syndrome:** PPIs are the DOC.

Question 218: Which of the following is beneficial in NSAID-induced gastric ulcer?

A. PGE1 agonist (Correct Answer)
B. PGE2 agonist
C. PGD agonist
D. PGF2 agonist

Explanation: The correct answer is **A. PGE1 agonist**. **Mechanism of Action:** NSAIDs induce gastric ulcers primarily by inhibiting the enzyme **Cyclooxygenase-1 (COX-1)**, which leads to a deficiency in endogenous prostaglandins (PGE2 and PGI2) in the gastric mucosa [2], [3]. These prostaglandins are essential for "cytoprotection" as they decrease gastric acid secretion, increase bicarbonate production, and enhance mucosal blood flow [4]. **Misoprostol**, a synthetic **PGE1 analog (agonist)**, acts as a replacement for these lost prostaglandins [1]. It binds to EP3 receptors on parietal cells to inhibit cAMP-mediated acid secretion, making it the drug of choice for the prevention of NSAID-induced ulcers [1]. **Analysis of Incorrect Options:** * **B. PGE2 agonist:** While endogenous PGE2 is naturally cytoprotective [2], the specific pharmacological agent used in clinical practice for NSAID-induced ulcer prophylaxis is a PGE1 derivative (Misoprostol) [1]. PGE2 analogs (like Dinoprostone) are primarily used in obstetrics for cervical ripening. * **C & D. PGD and PGF2 agonists:** These prostaglandins do not play a significant role in gastric mucosal protection. PGF2α (e.g., Carboprost, Latanoprost) is involved in uterine contraction and intraocular pressure regulation, while PGD2 is primarily involved in allergic responses and sleep regulation. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** While Misoprostol is the specific physiological antagonist for NSAID-induced ulcers, **Proton Pump Inhibitors (PPIs)** are more commonly used in clinical practice due to better tolerability [2]. * **Contraindication:** Misoprostol is strictly **contraindicated in pregnancy** (Category X) because it causes uterine contractions and can lead to abortion. * **Side Effects:** The most common side effect of Misoprostol is **diarrhea** and abdominal cramps.

Question 219: Which one of the following drugs exacerbates reflux esophagitis?

A. Cisapride
B. Chlorpropamide
C. Theophylline (Correct Answer)
D. Metoclopramide

Explanation: **Explanation:** The primary pathophysiological mechanism behind Gastroesophageal Reflux Disease (GERD) or reflux esophagitis is the relaxation of the **Lower Esophageal Sphincter (LES)** [1][3]. Any drug that decreases LES tone will exacerbate the condition. **Why Theophylline is correct:** Theophylline is a methylxanthine used in asthma and COPD [5]. It acts by inhibiting the enzyme **phosphodiesterase (PDE)**, leading to increased levels of intracellular **cAMP** [4]. In smooth muscles, elevated cAMP causes relaxation. When this occurs at the LES, it reduces the pressure barrier between the stomach and esophagus, allowing acidic gastric contents to reflux upwards, thereby exacerbating esophagitis [1]. **Why the other options are incorrect:** * **Cisapride:** This is a prokinetic agent that acts as a 5-HT4 receptor agonist [2]. It **increases** LES tone and enhances gastric emptying, making it a drug used to *treat* GERD, not exacerbate it. However, it is largely restricted due to the risk of **QT interval prolongation** [2]. * **Metoclopramide:** A D2 receptor antagonist with prokinetic properties. Like cisapride, it **increases** LES pressure and promotes upper GI motility, thus helping to *prevent* reflux. * **Chlorpropamide:** This is a first-generation sulfonylurea used in Diabetes Mellitus. It has no significant pharmacological effect on LES tone or esophageal motility. **High-Yield Clinical Pearls for NEET-PG:** * **Other drugs that exacerbate GERD:** Anticholinergics, Nitrates, Calcium Channel Blockers (CCBs), Progesterone, and Beta-agonists (all relax smooth muscle). * **Prokinetic of choice:** While Cisapride is effective, it is largely restricted due to the risk of **QT interval prolongation** (Torsades de pointes) [2]. * **Theophylline Toxicity:** Remember that Theophylline has a narrow therapeutic index; its metabolism is inhibited by Cimetidine and Erythromycin, increasing the risk of toxicity.

Question 220: Which of the following drugs does NOT cause peptic ulcer?

A. Clopidogrel
B. NSAID
C. Mycophenolate mofetil
D. Propylthiouracil (Correct Answer)

Explanation: **Explanation:** The correct answer is **Propylthiouracil (PTU)**. PTU is an antithyroid drug used in the management of hyperthyroidism and Graves' disease. Its primary mechanism involves inhibiting the enzyme thyroid peroxidase and blocking the peripheral conversion of T4 to T3 [1]. It is **not** associated with gastric mucosal injury or peptic ulcer disease (PUD). Its major side effects include agranulocytosis, hepatotoxicity, and ANCA-associated vasculitis [3]. **Analysis of Incorrect Options:** * **NSAIDs (e.g., Aspirin, Ibuprofen):** These are the most common pharmacological cause of PUD. They inhibit the COX-1 enzyme, leading to decreased synthesis of protective prostaglandins ($PGE_2$ and $PGI_2$), which are essential for maintaining the gastric mucosal barrier and bicarbonate secretion [2]. * **Clopidogrel:** While not directly ulcerogenic like NSAIDs, this antiplatelet agent impairs the healing of pre-existing gastric erosions by inhibiting platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF) required for mucosal repair. This significantly increases the risk of upper GI bleeding. * **Mycophenolate Mofetil (MMF):** This immunosuppressant is notorious for GI toxicity. It causes direct mucosal damage and inhibits the proliferation of rapidly dividing enterocytes, frequently leading to gastritis, erosions, and "MMF-induced colitis." **High-Yield Clinical Pearls for NEET-PG:** * **Steroids alone** have a low risk of causing ulcers, but when combined with **NSAIDs**, the risk of PUD increases exponentially (synergistic effect). * **Bisphosphonates** (e.g., Alendronate) and **Potassium chloride tablets** are other common causes of drug-induced esophageal and gastric ulcers. * **Prophylaxis:** For patients on long-term NSAIDs with high ulcer risk, **Misoprostol** ($PGE_1$ analogue) or **PPIs** are the drugs of choice for prevention.

Practice by Chapter

Acid-Peptic Disease Therapeutics

Practice Questions

Proton Pump Inhibitors

Practice Questions

H2 Receptor Antagonists

Practice Questions

Antacids and Mucosal Protectants

Practice Questions

Antiemetics

Practice Questions

Prokinetic Agents

Practice Questions

Laxatives and Purging Agents

Practice Questions

Antidiarrheal Drugs

Practice Questions

Drugs for Inflammatory Bowel Disease

Practice Questions

Pancreatic Enzyme Supplements

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free